Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion development in ApoE-deficient mice

被引：0
|
作者：
Ozaki, M [1 ]
Kawashima, S [1 ]
Yamashita, T [1 ]
Namiki, M [1 ]
Nakai, T [1 ]
Hirase, T [1 ]
Inoue, N [1 ]
Hirata, KI [1 ]
Yokoyama, M [1 ]
机构：
[1] Kobe Univ, Grad Sch Med, Kobe, Hyogo 650, Japan
来源：
CIRCULATION | 2001年 / 104卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1312
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [1] Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice
    Ozaki, M
    Kawashima, S
    Yamashita, T
    Hirase, T
    Namiki, M
    Inoue, N
    Hirata, K
    Yasui, H
    Sakurai, H
    Yoshida, Y
    Masada, M
    Yokoyama, M
    JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (03): : 331 - 340
  • [2] Overexpression of endothelial nitric oxide synthase deteriorates vascular remodeling in apoE-deficient mice
    Shinohara, M
    Kawashima, S
    Takaya, T
    Yamashita, T
    Inoue, N
    Hirata, KI
    Yokoyama, M
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2004, 11 (01): : 63 - 64
  • [3] A novel endothelial nitric oxide synthase expression enhancer reduces atherosclerosis in apoE-deficient mice
    Wohlfart, P
    Tiemann, M
    Strobel, H
    Suzuki, T
    Dharanipragada, R
    Li, H
    Foerstermann, U
    Ruetten, H
    CIRCULATION, 2002, 106 (19) : 213 - 213
  • [4] Development of atherosclerotic calcification in apoE-deficient mice
    Shioi, A
    Kizu, A
    Jono, S
    Koyama, H
    Okuno, Y
    Nishizawa, Y
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 151 - 152
  • [5] Folic acid supplementation delays atherosclerotic lesion development in apoE-deficient mice
    Carnicer, Ricardo
    Navarro, Maria A.
    Arbones-Mainar, Jose M.
    Acin, Sergio
    Guzman, Mario A.
    Surra, Joaquin C.
    Arnal, Carmen
    Heras, Marcelo de las
    Blanco-Vaca, Francisco
    Osada, Jesus
    LIFE SCIENCES, 2007, 80 (07) : 638 - 643
  • [6] Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice
    Enomoto, Soichiro
    Sata, Masataka
    Fukuda, Daiju
    Nakamura, Kazuto
    Nagai, Ryozo
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (01) : 19 - 26
  • [7] Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
    Erbel, Christian
    Chen, Lili
    Bea, Florian
    Wangler, Susanne
    Celik, Sultan
    Lasitschka, Felix
    Wang, Ying
    Boeckler, Dittmar
    Katus, Hugo A.
    Dengler, Thomas J.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (12): : 8167 - 8175
  • [8] Trypanosoma cruzi infection increases atherosclerotic lesion in ApoE-deficient mice
    Figueiredo, Vivian Paulino
    Silva, Maria Claudia
    de Souza, Debora Maria Soares
    Coelho Jr, Diogenes
    Lopes, Lais Roquete
    Azevedo, Maira de Araujo
    Menezes, Ana Paula de Jesus
    de Lima, Wanderson Geraldo
    Peluzio, Maria do Carmo Gouveia
    Talvani, Andre
    MICROBIAL PATHOGENESIS, 2022, 171
  • [9] Infection with Toxoplasma gondii increases atherosclerotic lesion in ApoE-deficient mice
    Portugal, LR
    Fernandes, LR
    Cesar, GC
    Santiago, HC
    Oliveira, DR
    Silva, NM
    Silva, AA
    Lannes-Vieira, J
    Arantes, RME
    Gazzinelli, RT
    Alvarez-Leite, JI
    INFECTION AND IMMUNITY, 2004, 72 (06) : 3571 - 3576
  • [10] TAT-beclin1 treatment accelerates the development of atherosclerotic lesions in ApoE-deficient mice
    Liu, Lianbo
    Wang, Qingjie
    Li, Yawen
    Cai, Jiali
    Wang, Yexing
    Li, Yun
    Wang, Ruxing
    Sun, Ling
    Zheng, Xiaowei
    Yin, Anwen
    FASEB JOURNAL, 2024, 38 (13):
12345